These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19750304)
1. [Neurofibromatosis type 1: more frequent and severe then usually thought]. Souza JF; Toledo LL; Ferreira MC; Rodrigues LO; Rezende NA Rev Assoc Med Bras (1992); 2009; 55(4):394-9. PubMed ID: 19750304 [TBL] [Abstract][Full Text] [Related]
2. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital. Cnossen MH; Moons KG; Garssen MP; Pasmans NM; de Goede-Bolder A; Niermeijer MF; Grobbee DE J Med Genet; 1998 Aug; 35(8):624-7. PubMed ID: 9719365 [TBL] [Abstract][Full Text] [Related]
3. Clinical severity in Japanese patients with neurofibromatosis 1 based on DNB classification. Ehara Y; Yamamoto O; Kosaki K; Yoshida Y J Dermatol; 2017 Nov; 44(11):1262-1267. PubMed ID: 29098729 [TBL] [Abstract][Full Text] [Related]
4. Voice-related quality of life in adults with neurofibromatosis type 1. Cosyns M; Mortier G; Janssens S; Van Borsel J J Voice; 2012 Mar; 26(2):e57-62. PubMed ID: 21550781 [TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 1 growth charts. Clementi M; Milani S; Mammi I; Boni S; Monciotti C; Tenconi R Am J Med Genet; 1999 Dec; 87(4):317-23. PubMed ID: 10588837 [TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1. Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358 [TBL] [Abstract][Full Text] [Related]
7. [Children with neurofibroma type 1 treated in the Children's Memorial Health Institute]. Perek-Polnik M; Filipek I; Dembowska-Bagińska B; Owsik A; Drogosiewicz M; Jurkiewicz E; Perek D Med Wieku Rozwoj; 2006; 10(3 Pt 1):699-709. PubMed ID: 17317901 [TBL] [Abstract][Full Text] [Related]
8. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects. Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428 [TBL] [Abstract][Full Text] [Related]
9. Speech disorders in neurofibromatosis type 1: a sample survey. Cosyns M; Vandeweghe L; Mortier G; Janssens S; Van Borsel J Int J Lang Commun Disord; 2010; 45(5):600-7. PubMed ID: 19900076 [TBL] [Abstract][Full Text] [Related]
10. Cognitive function and academic performance in children with neurofibromatosis type 1. North K; Joy P; Yuille D; Cocks N; Hutchins P Dev Med Child Neurol; 1995 May; 37(5):427-36. PubMed ID: 7768342 [TBL] [Abstract][Full Text] [Related]
11. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results]. Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272 [TBL] [Abstract][Full Text] [Related]
13. Growth in North American white children with neurofibromatosis 1 (NF1). Szudek J; Birch P; Friedman JM J Med Genet; 2000 Dec; 37(12):933-8. PubMed ID: 11106357 [TBL] [Abstract][Full Text] [Related]
14. Voice characteristics in adults with neurofibromatosis type 1. Cosyns M; Mortier G; Corthals P; Janssens S; Van Borsel J J Voice; 2011 Nov; 25(6):759-64. PubMed ID: 20951550 [TBL] [Abstract][Full Text] [Related]
15. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough? Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708 [TBL] [Abstract][Full Text] [Related]
16. Muscular force is reduced in neurofibromatosis type 1. Souza JF; Passos RL; Guedes AC; Rezende NA; Rodrigues LO J Musculoskelet Neuronal Interact; 2009; 9(1):15-7. PubMed ID: 19240363 [TBL] [Abstract][Full Text] [Related]
18. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Friedman JM; Birch PH Am J Med Genet; 1997 May; 70(2):138-43. PubMed ID: 9128932 [TBL] [Abstract][Full Text] [Related]
19. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165 [TBL] [Abstract][Full Text] [Related]
20. Muscle weakness in children with neurofibromatosis type 1. Cornett KM; North KN; Rose KJ; Burns J Dev Med Child Neurol; 2015 Aug; 57(8):733-6. PubMed ID: 25913846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]